Navigation Links
Cepheid Announces European Release of Xpert Flu, Delivering Simultaneous Detection and Differentiation of Flu A, Flu B, and 2009 H1N1 Strain
Date:12/27/2010

SUNNYVALE, Calif., Dec. 27, 2010 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced the release of Xpert® Flu as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. The test, which runs on Cepheid's GeneXpert® System, simultaneously detects and differentiates Flu A, Flu B, and 2009 H1N1 influenza virus in about one hour.

"While seasonal influenza strains appear to be of usual concern this season, the European resurgence of 2009 H1N1 highlights the critical need for accurate, rapid, and easy-to-use diagnostic solutions for all of the major influenza strains in circulation," said John Bishop, Cepheid's Chief Executive Officer. "Although molecular testing is now recognized as the new gold standard for detection of influenza, testing is generally limited to highly complex laboratories and results may not typically be available around the clock. Xpert Flu provides an easy-to-use, on-demand molecular influenza test that can assist clinicians in making real-time medical decisions 24 hours a day."

2009 H1N1 is a novel influenza virus first detected in the United States in April 2009. While no longer at pandemic levels(1), a December 2010 report from the European Centre for Disease Prevention and Control indicates that the start of the 2010-11 European influenza season is being dominated by 2009 H1N1 virus. The report goes on to recommend: "Countries should be prepared for increased demand for healthcare assistance and promote early sample collection and testing for patients with influenza-like-illness."(2)

Xpert Flu is available now as a CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Visit www.cepheidinternational.com for Cepheid's complete CE IVD menu of Xpert tests. Xpert Flu is expected to become avai
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
8. Cepheid Reports 2009 Third Quarter Results
9. Cepheid to Webcast Upcoming Financial Presentations
10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
11. Cepheid to Webcast Upcoming Financial Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Inc. (NASDAQ: CYBX ) today announced results for ... highlights 1   Operating results for the first ... fiscal 2014, and other achievements, include: , Worldwide net ... , Strong international net sales of $13.2 million, an increase ... net product sales reached a new high of $58.8 million, ...
(Date:8/21/2014)...   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced positive results from a randomized, double-blind Phase ... for the treatment of edematous fibrosclerotic panniculopathy (EFP), ... trial, all three doses of CCH (low (0.06mg), ... in the appearance of cellulite as measured by ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 27, 2011   , Strategic ... rest of the world except Nordics and the US , ... US market , Photocure ASA (OSE: PHO), a ... cancer, announces today the execution of a new commercial strategy ...
... 2011 Women ages 65-69 who break a hip are five ... the same age who don,t break a hip, according to a ... Institutes of Health and published online today in the Archives ... death risk by age group. In addition to the finding for ...
Cached Medicine Technology:Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 2Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 3Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 4Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 5Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 6Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 7Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 8Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 2Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 3Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 4
(Date:8/21/2014)... born at a low birth weight puts black women at ... The findings may partly explain high diabetes rates among ... low birth weight, the researchers added. Their study of ... low birth weight were 13 percent more likely to develop ... The risk of diabetes was 40 percent higher in those ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. 21, ... antidepressants appears to best help people with severe but ... of five people suffering from severe depression for less ... cognitive therapy plus antidepressant medication, researchers found. On ... than drugs alone in helping people with mild depression ...
(Date:8/21/2014)... August 21, 2014 Transvaginal mesh ... Inc. continue to move forward in the federal ... District of West Virginia, Bernstein Liebhard LLP reports. ... 14th, the Court has established new stipulated evidence ... handling, division, storage and preservation. (In re C.R. ...
(Date:8/21/2014)... August 21, 2014 Seattle, WA ... at Eastlake Chiropractic and Massage Center have ... growing team. Rina Lang, LMP and Mike Larios, ... range of massage techniques, and have developed their expertise ... This is particularly important in a clinical environment where ...
(Date:8/21/2014)... do not routinely screen women for intimate partner ... public health researchers. Rural women who are exposed ... seek help., "Rural health care providers are uniquely ... a primary care physician and assistant professor of ... of Medicine. "However, in rural settings, it might ...
Breaking Medicine News(10 mins):Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2
... ... preparedness and response efforts for the H1N1 pandemic have a new resource at their ... Minneapolis ... and response efforts for the H1N1 pandemic have a new resource at their disposal. ...
... Time for Senate to Act , WASHINGTON, Nov. 9 ... Win: , After generations of struggle and decades of delay, the ... to pass historic reform legislation to assure every American, regardless of ... House,s action this November is why working men and women turned ...
... The House version of health care reform - the Affordable ... of 220-215 on Saturday, November 7, 2009 - mandates several significant ... the tax provisions likely to appear in any Senate version, requiring ... Special Tax Briefing on the tax provisions of ...
... Churchill Centre today announced that it plans to bestow its ... commitment to promoting democracy through progressive free market practices and ... will receive his award at a ceremony and dinner on ... , "This is a testament to how Bill Marriott ...
... drugs that inhibit estrogen, , MONDAY, Nov. 9 (HealthDay ... and osteoporosis eliminated cervical cancer in mice, according to ... growths in the cervix and vagina, and prevented the ... The breast cancer drug fulvestrant and the breast cancer/osteoporosis ...
... ... Understanding the Effects of Genes , ... (Vocus) November 9, 2009 -- Understanding patients’ ancestries can be extraordinarily ... that scanned the genomes of 4,000 people throughout Europe and found clear regional differences, ...
Cached Medicine News:Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:News from the November/December Issue of Molecular Medicine 2
This catheter is intended for ultrasound examination of coronary intravascular pathology only. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
... is labeled with technetium 99m, MYOVIEW is ... regions of reversible myocardial ischemia in the ... and rest conditions. Imaging can begin as ... 4 hours after administration of MYOVIEW, enhancing ...
Universal Hub with Varying Blade Edge Diameters For Mounting the Blade to the Handle; Stainless Steel....
... Thallous Chloride Tl 201 Injection is supplied ... non-pyrogenic diagnostic radiopharmaceutical for intravenous administration. Each ... Chloride Tl 201 at calibration time, made ... preserved with 0.9% (v/v) benzyl alcohol. The ...
Medicine Products: